NO180544C - Fremgangsmåte for fremstilling av humant IL-3 (Pro-8), ekspresjonsvektor, vektor og transformert levende vertscelle - Google Patents

Fremgangsmåte for fremstilling av humant IL-3 (Pro-8), ekspresjonsvektor, vektor og transformert levende vertscelle

Info

Publication number
NO180544C
NO180544C NO883614A NO883614A NO180544C NO 180544 C NO180544 C NO 180544C NO 883614 A NO883614 A NO 883614A NO 883614 A NO883614 A NO 883614A NO 180544 C NO180544 C NO 180544C
Authority
NO
Norway
Prior art keywords
vector
pro
human
preparation
host cell
Prior art date
Application number
NO883614A
Other languages
English (en)
Norwegian (no)
Other versions
NO883614L (no
NO883614D0 (no
NO180544B (no
Inventor
Lambertus Christiaan Dorssers
Gerard Wagemaker
Yvonne Johanna Vos
Robert Willem Van Leen
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of NO883614L publication Critical patent/NO883614L/no
Publication of NO883614D0 publication Critical patent/NO883614D0/no
Publication of NO180544B publication Critical patent/NO180544B/no
Publication of NO180544C publication Critical patent/NO180544C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO883614A 1986-12-16 1988-08-12 Fremgangsmåte for fremstilling av humant IL-3 (Pro-8), ekspresjonsvektor, vektor og transformert levende vertscelle NO180544C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP86202285 1986-12-16
EP87201322 1987-07-13
PCT/NL1987/000037 WO1988004691A1 (en) 1986-12-16 1987-12-16 Molecular cloning and expression of human il-3

Publications (4)

Publication Number Publication Date
NO883614L NO883614L (no) 1988-08-12
NO883614D0 NO883614D0 (no) 1988-08-12
NO180544B NO180544B (no) 1997-01-27
NO180544C true NO180544C (no) 1997-05-07

Family

ID=26103432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883614A NO180544C (no) 1986-12-16 1988-08-12 Fremgangsmåte for fremstilling av humant IL-3 (Pro-8), ekspresjonsvektor, vektor og transformert levende vertscelle

Country Status (14)

Country Link
JP (2) JPH01502157A (de)
AT (1) ATE161882T1 (de)
AU (1) AU617095B2 (de)
CA (1) CA1341503C (de)
DE (1) DE3752158T2 (de)
ES (1) ES2113338T3 (de)
FI (1) FI102293B1 (de)
GR (1) GR3025857T3 (de)
IE (1) IE81129B1 (de)
IL (1) IL84852A (de)
NO (1) NO180544C (de)
NZ (1) NZ222939A (de)
PT (1) PT86381B (de)
WO (1) WO1988004691A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US6238889B1 (en) 1986-12-16 2001-05-29 Dsm N.V. Molecular cloning and expression of the Pro8 isoform of human IL-3
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
GB2210883B (en) * 1987-10-08 1992-01-02 British Bio Technology Synthetic interleukin-3 gene
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
JPH04500508A (ja) * 1988-07-20 1992-01-30 イミュネックス・コーポレーション 非グリコシル化　ヒト　インターロイキン―３　組成物
NZ232913A (en) * 1989-03-15 1992-08-26 Gist Brocades Nv Il-3 produced recombinantly and purified to homogeneity; vectors and pharmaceutical preparations
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
EP0413383B1 (de) 1989-08-14 1997-06-18 Gist-Brocades N.V. Mutanten von Interleukin-3
US5516512A (en) 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
DK0596881T3 (da) * 1991-08-01 1997-10-13 Fond Nat Transfusion Sanguine Ekspression i ikke-tumurale humane lymofoblastoider med en integrativ vektor
ATE238421T1 (de) * 1992-11-24 2003-05-15 Searle & Co Interleukin-3 (il-3)-polypeptide mith mehreren mutationen
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO1999041382A2 (en) * 1998-02-17 1999-08-19 Hyseq, Inc. A novel interleukin-3 and uses thereof
JP2008527981A (ja) * 2005-01-25 2008-07-31 アポロ ライフ サイエンシズ リミテッド 治療目的および診断目的のためにパラメーターにより選択されたｇｍ−ｃｓｆ、ｉｌ−３、ｉｌ−４、ｉｌ−５、ならびにそのキメラ
EP2001905A1 (de) * 2006-04-03 2008-12-17 New England Biolabs, Inc. Expression, sekretion und reinigung von rekombinantem rinderserumalbumin (rbsa) und dessen verwendung
WO2024033522A1 (en) 2022-08-11 2024-02-15 Universitätsklinikum Regensburg Antibodies targeting il3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
AU570762B2 (en) * 1983-12-23 1988-03-24 Australian National University, The Cloning of cdna for il-3
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors

Also Published As

Publication number Publication date
JPH01502157A (ja) 1989-08-03
NO883614L (no) 1988-08-12
NO883614D0 (no) 1988-08-12
WO1988004691A1 (en) 1988-06-30
DE3752158D1 (de) 1998-02-12
FI102293B (fi) 1998-11-13
NZ222939A (en) 1991-03-26
PT86381B (pt) 1990-11-20
IL84852A (en) 1994-06-24
FI102293B1 (fi) 1998-11-13
JPH1080286A (ja) 1998-03-31
ES2113338T3 (es) 1998-05-01
AU617095B2 (en) 1991-11-21
GR3025857T3 (en) 1998-04-30
FI883688L (fi) 1988-08-08
IL84852A0 (en) 1988-06-30
AU1057788A (en) 1988-07-15
IE81129B1 (en) 2000-03-22
ATE161882T1 (de) 1998-01-15
IE873409L (en) 1988-06-12
CA1341503C (en) 2006-04-04
DE3752158T2 (de) 1998-05-20
PT86381A (en) 1988-01-01
FI883688A0 (fi) 1988-08-08
NO180544B (no) 1997-01-27

Similar Documents

Publication Publication Date Title
NO180544C (no) Fremgangsmåte for fremstilling av humant IL-3 (Pro-8), ekspresjonsvektor, vektor og transformert levende vertscelle
Ramamurthy et al. Diabetes increases collagenase activity in extracts of rat gingiva and skin
Eaton et al. Sickle cell hemoglobin polymerization
DE3884191D1 (de) Verarbeitungsverfahren von Signalen, besonders für Oximetriemessungen im lebenden menschlichen Gewebe.
MY102806A (en) Human interleukin-3 and muteins thereof
DE69333802T8 (de) Äusseres membranprotein von haemophilus
ATE237339T1 (de) Verwendung des modifizierten eigenen blutes zur behandlung von autoimmunerkrankungen
ES8301645A1 (es) "perfeccionamientos en los aparatos estimuladores para la hemodialisis".
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
HUP0003505A2 (hu) Aminoterminálisa felől csonkolt RANTES, mint kemokinantagonista
DE3376524D1 (en) Skin treatment composition
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
ATE175425T1 (de) Methode für die präparation von pyridoxyliertem hämoglobin
ES8707565A1 (es) Un procedimiento para producir un anticuerpo monoclonal
JPS5731622A (en) Production of human somatropin
DE68924222D1 (de) Megakaryocytopoietin, seine Herstellung und Benutzung.
ATE176154T1 (de) Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten
EP0516845A4 (de) Neuer megakaryokytischer koloniestimulierender faktor und verfahren zur herstellung.
JPS6480298A (en) Production of human proapolipoprotein a-i-like protein
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
SU605608A1 (ru) Способ исследовани ветвей магистральных кровеносных сосудов
KR870004142A (ko) 인터로이킨-2 유도체의 제조방법
Sugiyanto et al. Nutritional status of dengue haemorrhagic fever in children

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2003